ImmunoMet Competitors and Similar CompaniesClear all
ImmunoMet's competitors and similar companies include LadRx and MiNK Therapeutics.
 ImmunoMet ImmunoMet is a clinical-stage biotechnological company that specializes in tumor metabolism and immuno-metabolism. |  LadRx LadRx Corporation (formerly known as CytRx Corporation) is a biopharmaceutical company focused on discovering, developing and commercializing new therapeutics to treat patients with cancer. |  MiNK Therapeutics MiNK Therapeutics (formerly AgenTus Biosciences, AgenTus Therapeutics) is a biopharmaceutical company that develops allogeneic iNKT cell therapies to treat cancer and immune-mediated diseases. | |
Founding Date | Founding Date 2015 | Founding Date 1985 | Founding Date 2017 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Houston, US HQ | Locations Los Angeles, US HQ | Locations New York, US HQ Cambridge, GB |
Employees | Employees 814% increase | Employees 385% decrease | Employees 34 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 901.1 k | Valuation ($) 28.9 m |
Financial | |||
Net income | Net income N/A | Net income ($1.6m) (FY, 2024) | Net income ($12.5m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
LadRx
HQ
Los Angeles, US
Employees
3
LadRx Corporation (formerly known as CytRx Corporation) is a biopharmaceutical company focused on discovering, developing and commercializing new therapeutics to treat patients with cancer.
View companyMiNK Therapeutics
HQ
New York, US
Employees
34
MiNK Therapeutics (formerly AgenTus Biosciences, AgenTus Therapeutics) is a biopharmaceutical company that develops allogeneic iNKT cell therapies to treat cancer and immune-mediated diseases.
View company